1. Home
  2. BANF vs LQDA Comparison

BANF vs LQDA Comparison

Compare BANF & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BancFirst Corporation

BANF

BancFirst Corporation

HOLD

Current Price

$116.49

Market Cap

3.9B

Sector

Finance

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$30.59

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BANF
LQDA
Founded
1984
2004
Country
United States
United States
Employees
2135
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BANF
LQDA
Price
$116.49
$30.59
Analyst Decision
Hold
Strong Buy
Analyst Count
2
10
Target Price
$129.50
$38.60
AVG Volume (30 Days)
77.0K
1.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.76%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$13,996,000.00
Revenue This Year
$6.10
$993.31
Revenue Next Year
$3.92
$219.14
P/E Ratio
$16.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$97.02
$11.26
52 Week High
$138.15
$46.67

Technical Indicators

Market Signals
Indicator
BANF
LQDA
Relative Strength Index (RSI) 54.09 33.46
Support Level $106.33 $21.56
Resistance Level $124.87 $36.07
Average True Range (ATR) 3.35 2.65
MACD -0.42 -1.23
Stochastic Oscillator 50.72 11.10

Price Performance

Historical Comparison
BANF
LQDA

About BANF BancFirst Corporation

BancFirst Corp is engaged in providing banking services. The company's business unit includes BancFirst metropolitan banks, BancFirst community banks, Pegasus Bank, Worthington, other financial services and executive, operations and support. BancFirst metropolitan banks, BancFirst community banks, Pegasus and Worthington offer traditional banking products such as commercial and retail lending and a full line of deposit accounts. Other financial services are specialty product business units including guaranteed small business lending, residential mortgage lending, trust services, securities brokerage, electronic banking, and insurance.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: